Jiangsu CoWin Biotech Co., Ltd. (SHSE: 688426)
Health Care · Biotechnology · CN
CN¥19.12
+2.30% today · -20.8% 1Y
Jiangsu CoWin Biotech Co., Ltd. (SHSE: 688426) operates in the Biotechnology industry within the Health Care sector. The company is valued at $311.64M.
Over the last twelve months the share price has lost 20.8%, trading between 14.42 and 33.67.
Tweenvest scores Jiangsu CoWin Biotech Co., Ltd. across four factors: quality 57/100, value 70/100, growth 100/100. Its strongest factor is growth.
688426 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $311.64M
- Revenue (TTM)
- $30.38M
- P/E
- —
- EPS
- -0.91
- Dividend yield
- —
- Beta (5Y)
- 0.76
- 52-week high
- CN¥33.67
- 52-week low
- CN¥14.42
- Avg volume (3M)
- —
- Shares outstanding
- 109.93M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $138.89 | -4.26% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.